QPCT
Basic information
Region (hg38): 2:37342827-37373322
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the QPCT gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 28 | 29 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 28 | 0 | 1 |
Variants in QPCT
This is a list of pathogenic ClinVar variants found in the QPCT region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-37344750-C-T | not specified | Uncertain significance (Apr 24, 2024) | ||
2-37344813-G-C | not specified | Uncertain significance (Feb 13, 2024) | ||
2-37344832-C-T | not specified | Uncertain significance (Jul 20, 2022) | ||
2-37344850-A-C | not specified | Uncertain significance (Feb 05, 2024) | ||
2-37352892-T-C | not specified | Uncertain significance (Jan 31, 2024) | ||
2-37359604-C-T | not specified | Uncertain significance (Nov 09, 2021) | ||
2-37359649-A-C | not specified | Uncertain significance (Oct 17, 2023) | ||
2-37359656-A-G | not specified | Uncertain significance (Jan 25, 2023) | ||
2-37359796-G-A | not specified | Uncertain significance (Nov 09, 2021) | ||
2-37359810-G-T | not specified | Uncertain significance (Mar 27, 2023) | ||
2-37359826-C-T | not specified | Uncertain significance (Aug 26, 2022) | ||
2-37359827-G-A | not specified | Uncertain significance (Jul 25, 2023) | ||
2-37367233-C-G | not specified | Uncertain significance (Nov 08, 2022) | ||
2-37367317-A-T | not specified | Uncertain significance (Aug 04, 2021) | ||
2-37367335-G-A | not specified | Uncertain significance (Feb 06, 2024) | ||
2-37367341-T-C | not specified | Uncertain significance (Aug 04, 2023) | ||
2-37367356-C-T | not specified | Uncertain significance (Mar 15, 2024) | ||
2-37367359-C-T | not specified | Uncertain significance (Sep 06, 2022) | ||
2-37367384-A-C | not specified | Uncertain significance (May 25, 2022) | ||
2-37369709-A-G | not specified | Uncertain significance (Nov 30, 2021) | ||
2-37369727-A-G | not specified | Uncertain significance (Oct 29, 2021) | ||
2-37369739-T-G | not specified | Uncertain significance (Dec 22, 2023) | ||
2-37369742-T-A | not specified | Uncertain significance (Aug 04, 2021) | ||
2-37372400-G-C | not specified | Uncertain significance (Feb 03, 2022) | ||
2-37372407-G-A | not specified | Likely benign (May 13, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
QPCT | protein_coding | protein_coding | ENST00000338415 | 7 | 28749 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.20e-15 | 0.00583 | 125520 | 0 | 228 | 125748 | 0.000907 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.940 | 234 | 197 | 1.19 | 0.0000101 | 2330 |
Missense in Polyphen | 93 | 81.998 | 1.1342 | 993 | ||
Synonymous | -0.345 | 83 | 79.1 | 1.05 | 0.00000423 | 717 |
Loss of Function | -0.319 | 22 | 20.4 | 1.08 | 0.00000120 | 217 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00181 | 0.00181 |
Ashkenazi Jewish | 0.00109 | 0.00109 |
East Asian | 0.000272 | 0.000272 |
Finnish | 0.000185 | 0.000185 |
European (Non-Finnish) | 0.00121 | 0.00121 |
Middle Eastern | 0.000272 | 0.000272 |
South Asian | 0.000523 | 0.000523 |
Other | 0.000652 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Responsible for the biosynthesis of pyroglutamyl peptides. Has a bias against acidic and tryptophan residues adjacent to the N-terminal glutaminyl residue and a lack of importance of chain length after the second residue. Also catalyzes N-terminal pyroglutamate formation. In vitro, catalyzes pyroglutamate formation of N-terminally truncated form of APP amyloid-beta peptides [Glu-3]-amyloid-beta. May be involved in the N-terminal pyroglutamate formation of several amyloid-related plaque-forming peptides. {ECO:0000269|PubMed:15063747, ECO:0000269|PubMed:18486145, ECO:0000269|PubMed:21288892}.;
- Pathway
- Neutrophil degranulation;Innate Immune System;Immune System
(Consensus)
Recessive Scores
- pRec
- 0.267
Intolerance Scores
- loftool
- 0.876
- rvis_EVS
- 0.31
- rvis_percentile_EVS
- 72.6
Haploinsufficiency Scores
- pHI
- 0.346
- hipred
- N
- hipred_score
- 0.187
- ghis
- 0.474
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.222
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Qpct
- Phenotype
- homeostasis/metabolism phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- cellular protein modification process;peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase;neutrophil degranulation
- Cellular component
- extracellular region;specific granule lumen;extracellular exosome;tertiary granule lumen;ficolin-1-rich granule lumen
- Molecular function
- zinc ion binding;glutaminyl-peptide cyclotransferase activity